A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma

Unlabelled: Metastasis is the leading cause of death in patients with osteosarcoma, the most common pediatric bone malignancy. We conducted a multistage genome-wide association study of osteosarcoma metastasis at diagnosis in 935 osteosarcoma patients to determine whether germline genetic variation contributes to risk of metastasis. We identified an SNP, rs7034162, in NFIB significantly associated with metastasis in European osteosarcoma cases, as well as in cases of African and Brazilian ancestry (meta-analysis of all cases: P = 1.2 × 10(-9); OR, 2.43; 95% confidence interval, 1.83-3.24). The risk allele was significantly associated with lowered NFIB expression, which led to increased osteosarcoma cell migration, proliferation, and colony formation. In addition, a transposon screen in mice identified a significant proportion of osteosarcomas harboring inactivating insertions in Nfib and with lowered NFIB expression. These data suggest that germline genetic variation at rs7034162 is important in osteosarcoma metastasis and that NFIB is an osteosarcoma metastasis susceptibility gene.

Significance: Metastasis at diagnosis in osteosarcoma is the leading cause of death in these patients. Here we show data that are supportive for the NFIB locus as associated with metastatic potential in osteosarcoma.

Citing Articles

LncRNAs as potential prognosis/diagnosis markers and factors driving drug resistance of osteosarcoma, a review.

Hu S, Han X, Liu G, Wang S Front Endocrinol (Lausanne). 2024; 15:1415722.

PMID: 39015175 PMC: 11249743. DOI: 10.3389/fendo.2024.1415722.

CEP55, serving as a diagnostic marker gene for osteosarcoma, triggers the JAK2-STAT3-MMPs axis.

Yan Y, He J, Cheng W Ann Med Surg (Lond). 2024; 86(1):190-198.

PMID: 38222763 PMC: 10783210. DOI: 10.1097/MS9.0000000000001491.

Genetically inferred birthweight, height, and puberty timing and risk of osteosarcoma.

Gianferante D, Moore A, Spector L, Wheeler W, Yang T, Hubbard A Cancer Epidemiol. 2023; 92():102432.

PMID: 37596165 PMC: 10869637. DOI: 10.1016/j.canep.2023.102432.

Downregulation of miR-182-5p by NFIB promotes NAD+ salvage synthesis in colorectal cancer by targeting NAMPT.

Zhou L, Liu H, Chen Z, Chen S, Lu J, Liu C Commun Biol. 2023; 6(1):775.

PMID: 37491379 PMC: 10368701. DOI: 10.1038/s42003-023-05143-z.

Children's Oncology Group's 2023 blueprint for research: Epidemiology.

Lupo P, Marcotte E, Scheurer M, Poynter J, Spector L Pediatr Blood Cancer. 2023; 70 Suppl 6:e30566.

PMID: 37449937 PMC: 10519152. DOI: 10.1002/pbc.30566.

References

Moon H, Hwang K, Kim J, Kim H, Lee M, Jung E . NFIB is a potential target for estrogen receptor-negative breast cancers. Mol Oncol. 2011; 5(6):538-44. PMC: 5528324. DOI: 10.1016/j.molonc.2011.08.002. View

Bertucci F, Lagarde A, Ferrari A, Finetti P, Charafe-Jauffret E, Van Laere S . 8q24 Cancer risk allele associated with major metastatic risk in inflammatory breast cancer. PLoS One. 2012; 7(5):e37943. PMC: 3362533. DOI: 10.1371/journal.pone.0037943. View

Gorlick R, Khanna C . Osteosarcoma. J Bone Miner Res. 2010; 25(4):683-91. DOI: 10.1002/jbmr.77. View

Dooley A, Winslow M, Chiang D, Banerji S, Stransky N, Dayton T . Nuclear factor I/B is an oncogene in small cell lung cancer. Genes Dev. 2011; 25(14):1470-5. PMC: 3143937. DOI: 10.1101/gad.2046711. View

Patterson N, Price A, Reich D . Population structure and eigenanalysis. PLoS Genet. 2006; 2(12):e190. PMC: 1713260. DOI: 10.1371/journal.pgen.0020190. View

Sureshbabu A, Okajima H, Yamanaka D, Tonner E, Shastri S, Maycock J . IGFBP5 induces cell adhesion, increases cell survival and inhibits cell migration in MCF-7 human breast cancer cells. J Cell Sci. 2012; 125(Pt 7):1693-705. DOI: 10.1242/jcs.092882. View

Miller B, Cram P, Lynch C, Buckwalter J . Risk factors for metastatic disease at presentation with osteosarcoma: an analysis of the SEER database. J Bone Joint Surg Am. 2013; 95(13):e89. PMC: 3689260. DOI: 10.2106/JBJS.L.01189. View

Savage S, Mirabello L . Using epidemiology and genomics to understand osteosarcoma etiology. Sarcoma. 2011; 2011:548151. PMC: 3061299. DOI: 10.1155/2011/548151. View

Gronostajski R . Roles of the NFI/CTF gene family in transcription and development. Gene. 2000; 249(1-2):31-45. DOI: 10.1016/s0378-1119(00)00140-2. View

10.

Su Y, Wagner E, Luo Q, Huang J, Chen L, He B . Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma. Oncogene. 2011; 30(37):3907-17. DOI: 10.1038/onc.2011.97. View

11.

Kappel C, Hirschfeld S, Helman L . Human osteosarcoma cell lines are dependent on insulin-like growth factor I for in vitro growth. Cancer Res. 1994; 54(10):2803-7. View

12.

Schneider M, Zhou R, Hoeflich A, Krebs O, Schmidt J, Mohan S . Insulin-like growth factor-binding protein-5 inhibits growth and induces differentiation of mouse osteosarcoma cells. Biochem Biophys Res Commun. 2001; 288(2):435-42. DOI: 10.1006/bbrc.2001.5785. View

13.

Wang Z, Jacobs K, Yeager M, Hutchinson A, Sampson J, Chatterjee N . Improved imputation of common and uncommon SNPs with a new reference set. Nat Genet. 2011; 44(1):6-7. PMC: 3276401. DOI: 10.1038/ng.1044. View

14.

Bielack S, Kempf-Bielack B, Delling G, Exner G, Flege S, Helmke K . Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002; 20(3):776-90. DOI: 10.1200/JCO.2002.20.3.776. View

15.

Persson M, Andren Y, Mark J, Horlings H, Persson F, Stenman G . Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci U S A. 2009; 106(44):18740-4. PMC: 2773970. DOI: 10.1073/pnas.0909114106. View

16.

Musselman J, Bergemann T, Ross J, Sklar C, Silverstein K, Langer E . Case-parent analysis of variation in pubertal hormone genes and pediatric osteosarcoma: a Children's Oncology Group (COG) study. Int J Mol Epidemiol Genet. 2012; 3(4):286-93. PMC: 3508538. View

17.

Mirabello L, Troisi R, Savage S . Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer. 2009; 115(7):1531-43. PMC: 2813207. DOI: 10.1002/cncr.24121. View

18.

Ward L, Kellis M . HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2011; 40(Database issue):D930-4. PMC: 3245002. DOI: 10.1093/nar/gkr917. View

19.

Fujita S, Ito T, Mizutani T, Minoguchi S, Yamamichi N, Sakurai K . miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J Mol Biol. 2008; 378(3):492-504. DOI: 10.1016/j.jmb.2008.03.015. View

20.

Goulding H, Pinder S, Cannon P, Pearson D, Nicholson R, Snead D . A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples. Hum Pathol. 1995; 26(3):291-4. DOI: 10.1016/0046-8177(95)90060-8. View